Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor.

Shares of AbbVie Inc. ABBV inched 0.60% higher to $201.68 Tuesday, on what proved to be an all-around great trading session ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

On Friday, AbbVie Inc (ABBV) stock saw a decline, ending the day at $203.55 which represents a decrease of $-0.32 or -0.16% from the prior close of $203.87. The stock opened at $204.37 and touched a ...

EvolveImmune Therapeutics Inc., a Branford-based bioscience company developing therapeutics to overcome cancer cell ...

Discover the major biotech partnerships, collaborations, and mergers and acquisitions that made headlines in October 2024.

AbbVie has entered into a partnership and option-to-license agreement with EvolveImmune Therapeutics, to develop ...

Eli Lilly CEO David Ricks told investors this week that the sale of cheaper, knockoff versions of the company’s blockbuster ...

UChicago Medicine has received a $75 million gift from the AbbVie Foundation — a nonprofit focused on advancing health equity — to support the development of its new 575,000-square-foot cancer ...

Steve Grzanich has the business news of the day with the Wintrust Business Minute. A $75 million donation from the AbbVie Foundation will help University of Chicago Medicine build its new cancer ...

Learn more about the new cancer pavilion for UChicago, the leaders of which hope will one day be a leading institution for ...

Analyst Charlie CY Yang of Bank of America Securities reiterated a Hold rating on AbbVie (ABBV – Research Report), with a price target of ...